International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Clinical trial NCT01252693 · COMPLETED
Trial details
- NCT number
- NCT01252693
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2014-09-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.